Your browser doesn't support javascript.
loading
Kinetics of SARS-CoV-2 Serum Antibodies Through the Alpha, Delta, and Omicron Surges Among Vaccinated Health Care Workers at a Boston Hospital.
Dodge, Maura C; Ye, Lei; Duffy, Elizabeth R; Cole, Manisha; Gawel, Susan H; Werler, Martha M; Daghfal, David; Andry, Chris; Kataria, Yachana.
Affiliation
  • Dodge MC; Department of Pathology and Laboratory Medicine, Boston Medical Center, Boston, Massachusetts, USA.
  • Ye L; Department of Biostatistics, Abbott Core Diagnostics, Abbott Park, Illinois, USA.
  • Duffy ER; Department of Pathology and Laboratory Medicine, Chobanian and Avedisian School of Medicine, Boston University, Boston, Massachusetts, USA.
  • Cole M; Department of Pathology and Laboratory Medicine, Chobanian and Avedisian School of Medicine, Boston University, Boston, Massachusetts, USA.
  • Gawel SH; Department of Biostatistics, Abbott Core Diagnostics, Abbott Park, Illinois, USA.
  • Werler MM; Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts, USA.
  • Daghfal D; Department of Biostatistics, Abbott Core Diagnostics, Abbott Park, Illinois, USA.
  • Andry C; Department of Pathology and Laboratory Medicine, Boston Medical Center, Boston, Massachusetts, USA.
  • Kataria Y; Department of Pathology and Laboratory Medicine, Chobanian and Avedisian School of Medicine, Boston University, Boston, Massachusetts, USA.
Open Forum Infect Dis ; 10(7): ofad266, 2023 Jul.
Article in En | MEDLINE | ID: mdl-37396669
ABSTRACT

Background:

Longitudinal serology studies can assist in analyzing the kinetics of antibodies to SARS-CoV-2, helping to inform public health decision making. Our study aims to characterize circulating antibody trends over 18 months in vaccinated participants with and without evidence of COVID-19 infection.

Methods:

A cohort of health care workers employed at Boston Medical Center was followed to collect serum samples and survey data over 6 time points from July 2020 through December 2021 (N = 527). History of SARS-CoV-2 infection, vaccination, and booster status were confirmed, where possible, through electronic medical records. Serum was assessed for the qualitative and semiquantitative detection of IgG antibody levels (anti-nucleoprotein [anti-N] and anti-spike [anti-S], respectively). Piecewise regression models were utilized to characterize antibody kinetics over time.

Results:

Anti-S IgG titers remained above the positivity threshold following infection and/or vaccination throughout the 18-month follow-up. Among participants with no evidence of COVID-19 infection, titers declined significantly faster in the initial 90 days after full vaccination (ß = -0.056) from December 2020 to March 2021 as compared with the decline observed following booster dose uptake (ß = -0.023, P < 0.001). Additionally, COVID-19 infection prior to vaccination significantly attenuated the decline of anti-S IgG when compared with no infection following vaccine uptake (P < 0.001). Lastly, fewer participants contracted Omicron when boosted (12.7%) compared to fully vaccinated (17.6%). Regardless of vaccination status, participants who were Omicron positive had lower anti-S IgG titers than those who did not test positive, but this difference was not significant.

Conclusions:

These findings provide novel 18-month kinetics of anti-S IgG antibodies and highlight the durability of hybrid immunity, underlining the strong humoral response stimulated by combined infection and vaccination.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Qualitative_research Language: En Journal: Open Forum Infect Dis Year: 2023 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Qualitative_research Language: En Journal: Open Forum Infect Dis Year: 2023 Document type: Article Affiliation country: Estados Unidos